199 related articles for article (PubMed ID: 16885896)
21. [Muir-Torre syndrome].
Körber J; Djawari D
Hautarzt; 2001 Dec; 52(12):1107-10. PubMed ID: 11910863
[TBL] [Abstract][Full Text] [Related]
22. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B
Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344
[TBL] [Abstract][Full Text] [Related]
23. A Case of Muir-Torre Syndrome.
Sheth R; Menon P; Malik D
Cureus; 2021 Apr; 13(4):e14582. PubMed ID: 34036002
[TBL] [Abstract][Full Text] [Related]
24. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome.
Machin P; Catasus L; Pons C; Muñoz J; Conde-Zurita JM; Balmaña J; Barnadas M; Martí RM; Prat J; Matias-Guiu X
J Cutan Pathol; 2002 Aug; 29(7):415-20. PubMed ID: 12139636
[TBL] [Abstract][Full Text] [Related]
25. Sebaceous gland adenoma of the palpebral conjunctiva in a patient with Muir-Torre-syndrome: a case report.
Meier-Gibbons F; Messmer E
Graefes Arch Clin Exp Ophthalmol; 1994 Dec; 232(12):734-6. PubMed ID: 7890187
[TBL] [Abstract][Full Text] [Related]
26. [Sebaceous hyperplasia of the lower eyelid].
Spraul CW; Jakobczyk-Zmija MJ; Lang GK
Klin Monbl Augenheilkd; 1999 Nov; 215(5):319-20. PubMed ID: 10609249
[TBL] [Abstract][Full Text] [Related]
27. A Muir-Torre syndrome family.
Serleth HJ; Kisken WA
Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152
[TBL] [Abstract][Full Text] [Related]
28. [Muir-Torre syndrome].
Tiszlavicz L; Hódi Z; Tihanyi Z
Orv Hetil; 1999 Jan; 140(5):251-4. PubMed ID: 10064979
[TBL] [Abstract][Full Text] [Related]
29. The Muir-Torre syndrome: a 25-year retrospect.
Schwartz RA; Torre DP
J Am Acad Dermatol; 1995 Jul; 33(1):90-104. PubMed ID: 7601953
[TBL] [Abstract][Full Text] [Related]
30. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
31. Metastatic adenocarcinoma to the retina in a patient with Muir-Torre syndrome.
Spraul CW; Lang GE; Grossniklaus HE; Lang GK
Am J Ophthalmol; 1995 Aug; 120(2):248-50. PubMed ID: 7639310
[TBL] [Abstract][Full Text] [Related]
32. Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.
Holbach LM; von Moller A; Decker C; Jünemann AG; Rummelt-Hofmann C; Ballhausen WG
Am J Ophthalmol; 2002 Jul; 134(1):147-8. PubMed ID: 12095833
[TBL] [Abstract][Full Text] [Related]
33. Metachronous occurrence of colorectal cancer in a muir-torre syndrome patient presenting with recurrent sebaceous adenoma of the eyelid: case report and updated review of the literature.
Agiannidis C; Pana ZD; Molyva D; Kalokasidis K; Mixiou M
J Cutan Med Surg; 2012; 16(6):394-9. PubMed ID: 23149194
[TBL] [Abstract][Full Text] [Related]
34. [Sebaceous tumors and Muir-Torre syndrome].
Bourlond F; Cribier B; Lipsker D; Velter C
Ann Dermatol Venereol; 2015; 142(6-7):456-9. PubMed ID: 25890836
[No Abstract] [Full Text] [Related]
35. A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.
Vernez M; Hutter P; Monnerat C; Halkic N; Gugerli O; Bouzourene H
Fam Cancer; 2007; 6(1):141-5. PubMed ID: 17051350
[TBL] [Abstract][Full Text] [Related]
36. Muir-Torre syndrome.
Ponti G; Ponz de Leon M
Lancet Oncol; 2005 Dec; 6(12):980-7. PubMed ID: 16321766
[TBL] [Abstract][Full Text] [Related]
37. Muir-Torre syndrome and early detection of internal malignancy.
Chen CS; Loweinstein L; James C; Huilgol SC; Selva D
Med J Aust; 2003 Apr; 178(8):368. PubMed ID: 12776718
[No Abstract] [Full Text] [Related]
38. Muir-torre syndrome: a case report.
Higgins HJ; Voutsalath M; Holland JM
J Clin Aesthet Dermatol; 2009 Aug; 2(8):30-2. PubMed ID: 20729952
[TBL] [Abstract][Full Text] [Related]
39. Muir-Torre syndrome: clinical features and molecular genetic analysis.
Esche C; Kruse R; Lamberti C; Friedl W; Propping P; Lehmann P; Ruzicka T
Br J Dermatol; 1997 Jun; 136(6):913-7. PubMed ID: 9217825
[TBL] [Abstract][Full Text] [Related]
40. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
